357 related articles for article (PubMed ID: 7867143)
1. Vaccination against typhoid fever: present status.
Ivanoff B; Levine MM; Lambert PH
Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143
[TBL] [Abstract][Full Text] [Related]
2. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
3. The current status of typhoid vaccine development and clinical trials with typhoid vaccines.
Levine MM; Tacket CO; Herrington D; Losonsky G; Murphy J; Ferreccio C
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):459-69. PubMed ID: 3064323
[TBL] [Abstract][Full Text] [Related]
4. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
[TBL] [Abstract][Full Text] [Related]
5. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
6. Bacterial enteric infections and vaccine development.
Holmgren J; Svennerholm AM
Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
[TBL] [Abstract][Full Text] [Related]
8. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
Tacket CO; Levine MM
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S20-3. PubMed ID: 17582563
[TBL] [Abstract][Full Text] [Related]
9. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a live oral typhoid vaccine in human volunteers.
Hornick RB; DuPont HL; Levine MM; Gilman RH; Woodward WE; Snyder MJ; Woodward TE
Dev Biol Stand; 1976; 33():89-92. PubMed ID: 782976
[TBL] [Abstract][Full Text] [Related]
11. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries.
Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
Hum Vaccin; 2011 Aug; 7(8):883-5. PubMed ID: 21791973
[TBL] [Abstract][Full Text] [Related]
12. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
[TBL] [Abstract][Full Text] [Related]
13. [Vaccination against diarrheal diseases and typhoid fever. Current status and prospects].
Ivanoff B; Neira M
Ann Med Interne (Paris); 1998 Oct; 149(6):340-50. PubMed ID: 9853044
[TBL] [Abstract][Full Text] [Related]
14. Vaccines against typhoid fever.
Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
[TBL] [Abstract][Full Text] [Related]
15. Ineffectiveness of an oral killed typhoid vaccine in a field trial.
Chuttani CS; Prakash K; Vergese A; Gupta P; Chawla RK; Grover V; Agarwal DS
Bull World Health Organ; 1973 Jun; 48(6):754-5. PubMed ID: 4594320
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of oral killed typhoid vaccine.
Chuttani CS; Prakash K; Vergese A; Sharma U; Singha P; Ray BG
Bull World Health Organ; 1971; 45(4):445-50. PubMed ID: 4948415
[TBL] [Abstract][Full Text] [Related]
17. Population impact of Vi capsular polysaccharide vaccine.
Khan MI; Ochiai RL; Clemens JD
Expert Rev Vaccines; 2010 May; 9(5):485-96. PubMed ID: 20450323
[TBL] [Abstract][Full Text] [Related]
18. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.
Jain SK
Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505
[TBL] [Abstract][Full Text] [Related]
19. A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design.
Acosta CJ; Galindo CM; Ali M; Elyazeed RA; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Jin Y; Park JK; Lee H; Puri MK; Ivanoff B; Agtini MD; Soeharno R; Simanjuntak CH; Punjabi NH; Canh DG; Sur D; Nizami Q; Manna B; Bai-qing D; Anh DD; Honghui Y; Bhattacharya SK; Bhutta Z; Trach DD; Xu ZY; Pang T; Donner A; Clemens JD
Trop Med Int Health; 2005 Dec; 10(12):1219-28. PubMed ID: 16359401
[TBL] [Abstract][Full Text] [Related]
20. Safety of Typhim Vi vaccine in a postmarketing observational study.
Marcus LC; Froeschle JE; Hill DR; Wolfe MS; Maus D; Connor B; Acosta AM; Rensimer ER; Roberts A; Dardick K
J Travel Med; 2007; 14(6):386-91. PubMed ID: 17995534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
